ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 421701 | Rec_0434359 | LRR5M |
LGTNPLKSSGIE |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.24 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421702 | Rec_0434360 | LRR5M |
LGTNPLKSSGIE |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.21 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421703 | Rec_0434361 | LRR5C |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.25 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421704 | Rec_0434362 | LRR5C |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.26 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421705 | Rec_0434363 | LRR5C |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.27 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421706 | Rec_0434364 | LRR5C |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.26 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421707 | Rec_0434365 | LRR5C |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
0.25 absorbance at 460 nm | EZ4U cytotoxicity assessment (absorbance at 460 nm, 6 h) |
15923192 | - |
YES |
| 421708 | Rec_0434366 | LRR5 (FITC-labeled) |
QMIVIELGTNPLKSSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Collagen I |
27 ± 8.7 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421709 | Rec_0434367 | LRR5N (FITC-labeled) |
QMIVIELGTNPLK |
synthetic construct [Synthetic] |
- |
Collagen I |
45 ± 19.7 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421710 | Rec_0434368 | LRR5M (FITC-labeled) |
LGTNPLKSSGIE |
synthetic construct [Synthetic] |
- |
Collagen I |
58 ± 12.8 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421711 | Rec_0434369 | LRR5C (FITC-labeled) |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Collagen I |
308 ± 58.5 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421712 | Rec_0434370 | LRR5 (FITC-labeled) |
QMIVIELGTNPLKSSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Fibronectin |
808 ± 223.5 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421713 | Rec_0434371 | LRR5N (FITC-labeled) |
QMIVIELGTNPLK |
synthetic construct [Synthetic] |
- |
Fibronectin |
5140 ± 272.0 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421714 | Rec_0434372 | LRR5M (FITC-labeled) |
LGTNPLKSSGIE |
synthetic construct [Synthetic] |
- |
Fibronectin |
1400 ± 268.9 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421715 | Rec_0434373 | LRR5C (FITC-labeled) |
SSGIENGAFQGMK |
synthetic construct [Synthetic] |
- |
Fibronectin |
2760 ± 132.7 μM | Kd (FITC-peptide solid-phase binding, single-site nonlinear regression) |
15923192 | - |
YES |
| 421716 | Rec_0434374 | LRR5 |
QMIVIELGTNPLKSSGIENGAFQGMK |
synthetic construct [Synthetic] |
Anti-angiogenic |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
~100 nM | Estimated ED50 (VEGF-induced HUVEC tube formation on Matrigel, 4-6 h) |
15923192 | - |
YES |
| 421717 | Rec_0434375 | LRR5 |
QMIVIELGTNPLKSSGIENGAFQGMK |
synthetic construct [Synthetic] |
Anti-angiogenic |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
- | HUVEC tube formation on Matrigel (bFGF, 4-6 h) |
15923192 | - |
YES |
| 421718 | Rec_0434376 | LRR5N |
QMIVIELGTNPLK |
synthetic construct [Synthetic] |
- |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
- | HUVEC tube formation on Matrigel (VEGF, 4-6 h) |
15923192 | - |
YES |
| 421719 | Rec_0434377 | LRR5N |
QMIVIELGTNPLK |
synthetic construct [Synthetic] |
Anti-angiogenic |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
- | HUVEC tube formation on Matrigel (bFGF, 4-6 h) |
15923192 | - |
YES |
| 421720 | Rec_0434378 | LRR5M |
LGTNPLKSSGIE |
synthetic construct [Synthetic] |
Anti-angiogenic |
Homo sapiens (human umbilical vein endothelial cells, HUVECs) |
~100 pM | Estimated ED50 (VEGF-induced HUVEC tube formation on Matrigel, 4-6 h) |
15923192 | - |
YES |